Come up with a name for your new list and we'll add to it:
NeuroFx raised a round of funding on April 04, 2016. Investors include
Spring Mill Venture Partners.
NeuroFx is developing a cell-free therapeutic factor concentrate derived from adult adipose (fat) stem cells (NFx101). NFx101 has demonstrated great potential to halt brain injury caused by stroke, pr…